Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

In this article, we will look at the top 14 Biotech Stocks with High Potential. On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to ...

Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies ​are expected to go public amid a ...

Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve ...

In this article, we will take a look at 9 Oversold Biotech Stocks to Invest In. Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value ...

Skewed by a single company’s one-year drop, the largest public biotechs lose market capitalization for the second time in three years.

The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

The third-quarter 2025 reporting cycle of the Medical sector is currently approaching its end. The sector primarily comprises pharma/biotech and medical device companies. The Earnings Trends report ...